A detailed history of Exchange Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Exchange Bank holds 1,939 shares of ABBV stock, worth $343,106. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,939
Previous 1,939 -0.0%
Holding current value
$343,106
Previous $333 Million 15.13%
% of portfolio
0.31%
Previous 0.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $4,334 - $5,061
-28 Reduced 1.42%
1,939 $333 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $2,716 - $3,095
-17 Reduced 0.86%
1,967 $358 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $52,976 - $59,663
-385 Reduced 16.25%
1,984 $307 Million
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $7,881 - $9,124
-59 Reduced 2.43%
2,369 $353 Million
Q2 2023

Nov 15, 2023

BUY
$132.51 - $164.9 $321,734 - $400,377
2,428 New
2,428 $327 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Exchange Bank Portfolio

Follow Exchange Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Bank, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Bank with notifications on news.